CorMedix CRMD
NASDAQ CRMD
$8.20 -0.03 (-0.36%)
At close: Aug 21, 2026 · 4:00 PM EDT

CorMedix (CRMD) Change in Acquisitions & Divestments (2015 - 2025)

CorMedix (CRMD) posted Change in Acquisitions & Divestments of $3.6 million for Q4 2025, down 89.35% sequentially from $33.8 million in Q3 2025, and down 27.99% YoY from $5.0 million in Q4 2024.

CorMedix (CRMD) Change in Acquisitions & Divestments (2015 - 2025) Analysis & Trends

CorMedix has reported Change in Acquisitions & Divestments for 11 years, with the latest figure at $3.6 million in Q4 2025.

  • Quarterly Change in Acquisitions & Divestments fell 27.99% year-over-year to $3.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $55.3 million (up 14.92% YoY) and the FY2025 annual result came in at $55.3 million, up 14.92% from the prior year.
  • Change in Acquisitions & Divestments eased to $3.6 million in Q4 2025 per CRMD's latest filing, from $33.8 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $33.8 million in Q3 2025 and troughed at $13.0 in Q4 2021.
  • A 5-year average of $9.9 million and a median of $8.1 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
  • The sharpest annual moves came in 2021 and 2022: Change in Acquisitions & Divestments sank 100.0% in 2021, then surged 68461438.46% in 2022.
  • Over 5 years, Change in Acquisitions & Divestments stood at $13.0 in 2021, then soared by 68461438.46% to $8.9 million in 2022, then soared by 91.01% to $17.0 million in 2023, then sank by 70.59% to $5.0 million in 2024, then declined by 27.99% to $3.6 million in 2025.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $3.6 million, $33.8 million, and $8.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 CorMedix 645.20 Mn 388.51 Mn 77.13 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 3.60 Mn
Dec 31, 2025 3.60 Mn
Sep 30, 2025 33.79 Mn
Sep 30, 2025 33.79 Mn
Jun 30, 2025 8.10 Mn
Jun 30, 2025 8.10 Mn
Mar 31, 2025 9.80 Mn
Mar 31, 2025 9.80 Mn
Dec 31, 2024 5.00 Mn
Dec 31, 2024 5.00 Mn
Sep 30, 2024 8.00 Mn
Sep 30, 2024 8.00 Mn
Jun 30, 2024 18.42 Mn
Jun 30, 2024 18.42 Mn
Mar 31, 2024 16.70 Mn
Mar 31, 2024 16.70 Mn
Dec 31, 2023 17.00 Mn
Dec 31, 2023 17.00 Mn
Sep 30, 2023 17.50 Mn
Sep 30, 2023 17.50 Mn